ArticleBreast cancer (Tokyo, Japan)2023

HER2-targeted antibody-drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia.

Michael Rainone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.